Suppr超能文献

从跨损伤合成到同源依赖性缺口修复的时序转换

Chronological Switch from Translesion Synthesis to Homology-Dependent Gap Repair .

作者信息

Fujii Shingo, Isogawa Asako, Fuchs Robert P

机构信息

DNA Damage Tolerance CNRS, UMR7258, Marseille, France.

Institut Paoli-Calmettes, Marseille, France.

出版信息

Toxicol Res. 2018 Oct;34(4):297-302. doi: 10.5487/TR.2018.34.4.297. Epub 2018 Oct 15.

Abstract

Cells are constantly exposed to endogenous and exogenous chemical and physical agents that damage their genome by forming DNA lesions. These lesions interfere with the normal functions of DNA such as transcription and replication, and need to be either repaired or tolerated. DNA lesions are accurately removed via various repair pathways. In contrast, tolerance mechanisms do not remove lesions but only allow replication to proceed despite the presence of unrepaired lesions. Cells possess two major tolerance strategies, namely translesion synthesis (TLS), which is an error-prone strategy and an accurate strategy based on homologous recombination (homology-dependent gap repair [HDGR]). Thus, the mutation frequency reflects the relative extent to which the two tolerance pathways operate . In the present paper, we review the present understanding of the mechanisms of TLS and HDGR and propose a novel and comprehensive view of the way both strategies interact and are regulated .

摘要

细胞不断暴露于内源性和外源性化学及物理因子中,这些因子通过形成DNA损伤来破坏其基因组。这些损伤会干扰DNA的正常功能,如转录和复制,因此需要进行修复或耐受。DNA损伤可通过各种修复途径准确去除。相比之下,耐受机制并不去除损伤,而是仅允许复制在存在未修复损伤的情况下继续进行。细胞拥有两种主要的耐受策略,即跨损伤合成(TLS),这是一种易出错的策略,以及基于同源重组的准确策略(同源依赖性缺口修复[HDGR])。因此,突变频率反映了两种耐受途径发挥作用的相对程度。在本文中,我们综述了目前对TLS和HDGR机制的理解,并提出了关于这两种策略如何相互作用和受到调控的新颖而全面的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad65/6195876/b2bdadede826/tr-34-297f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验